Rocket Pharmaceuticals

News

Rocket aborts FDA filing for Fanconi gene therapy

Rocket Pharma has withdrawn a filing in the US for its experimental gene therapy for Fanconi anaemia, but may consider partnering the programme.

News

EMA starts review of Rocket’s Fanconi anaemia gene therapy

Patients in the EU with Fanconi anaemia (FA) could soon have the first gene therapy option for the disorder, as the EMA starts a review of Rocket Pharma’s RP-L102 candidat

News

Big Heavy Rocket Space Launch System Launch. 3D Illustration.

Rocket Pharmaceuticals in orbit after gene therapy read-out

Shares in Rocket Pharmaceuticals have been living up to their name, shooting up following encouraging early-stage clinical trial results from a gene therapy for a serious inherited rare hea

Rocket aborts FDA filing for Fanconi gene therapy

EMA starts review of Rocket’s Fanconi anaemia gene therapy

Rocket Pharmaceuticals in orbit after gene therapy read-out

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks